KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Short term Debt (2020 - 2021)

Ginkgo Bioworks Holdings (DNA) has disclosed Short term Debt for 2 consecutive years, with $631638.0 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Short term Debt changed N/A year-over-year to $631638.0, compared with a TTM value of $631638.0 through Jun 2021, changed N/A, and an annual FY2020 reading of $156333.0, changed N/A over the prior year.
  • Short term Debt was $631638.0 for Q2 2021 at Ginkgo Bioworks Holdings, up from $156333.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $631638.0 in Q2 2021 and bottomed at $156333.0 in Q4 2020.